BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22248288)

  • 1. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
    Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
    Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF21 N- and C-termini play different roles in receptor interaction and activation.
    Yie J; Hecht R; Patel J; Stevens J; Wang W; Hawkins N; Steavenson S; Smith S; Winters D; Fisher S; Cai L; Belouski E; Chen C; Michaels ML; Li YS; Lindberg R; Wang M; Véniant M; Xu J
    FEBS Lett; 2009 Jan; 583(1):19-24. PubMed ID: 19059246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FGFR D3 domain determines receptor selectivity for fibroblast growth factor 21.
    Gupte J; Yang L; Wu X; Weiszmann J; Hecht R; Lemon B; Lindberg R; Wang Z; Li Y
    J Mol Biol; 2011 May; 408(3):491-502. PubMed ID: 21392510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions.
    Kilkenny DM; Rocheleau JV
    Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions.
    Min X; Weiszmann J; Johnstone S; Wang W; Yu X; Romanow W; Thibault S; Li Y; Wang Z
    J Biol Chem; 2018 Sep; 293(38):14678-14688. PubMed ID: 30068552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex.
    Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV
    J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.
    Kumata C; Mizobuchi M; Ogata H; Koiwa F; Nakazawa A; Kondo F; Kadokura Y; Kinugasa E; Akizawa T
    Am J Nephrol; 2010; 31(3):230-8. PubMed ID: 20068287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
    Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF21 can be mimicked in vitro and in vivo by a novel anti-FGFR1c/β-Klotho bispecific protein.
    Smith R; Duguay A; Bakker A; Li P; Weiszmann J; Thomas MR; Alba BM; Wu X; Gupte J; Yang L; Stevens J; Hamburger A; Smith S; Chen J; Komorowski R; Moore KW; Véniant MM; Li Y
    PLoS One; 2013; 8(4):e61432. PubMed ID: 23630589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
    Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
    Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
    Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
    Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability.
    An SJ; Mohanty J; Tome F; Suzuki Y; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2219128120. PubMed ID: 36745784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
    Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
    Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of an artificial peptide agonist to the fibroblast growth factor receptor 1c/βKlotho complex from random peptide T7 phage display.
    Sakamoto K; Kawata Y; Masuda Y; Umemoto T; Ito T; Asami T; Takekawa S; Ohtaki T; Inooka H
    Biochem Biophys Res Commun; 2016 Nov; 480(1):55-60. PubMed ID: 27717820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
    Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
    Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FGF21 regulates metabolism and circadian behavior by acting on the nervous system.
    Bookout AL; de Groot MH; Owen BM; Lee S; Gautron L; Lawrence HL; Ding X; Elmquist JK; Takahashi JS; Mangelsdorf DJ; Kliewer SA
    Nat Med; 2013 Sep; 19(9):1147-52. PubMed ID: 23933984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Klotho gene family as a regulator of endocrine fibroblast growth factors.
    Kurosu H; Kuro-O M
    Mol Cell Endocrinol; 2009 Feb; 299(1):72-8. PubMed ID: 19063940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
    Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.